Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_assertion type Assertion NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_head.
- NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_assertion description "[Genomic deletion of DLC-1 was observed in 40% of breast tumors, whereas reduced levels of DLC-1 mRNA were seen in 70% of breast, 70% of colon, 50% of prostate tumor cell lines.DLC-1 gene plays a role in breast cancer by acting as a tumor suppressor gene]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_provenance.
- NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_assertion evidence source_evidence_literature NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_provenance.
- NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_assertion SIO_000772 12545165 NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_provenance.
- NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_assertion wasDerivedFrom lhgdn-20090331 NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_provenance.
- NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_assertion wasGeneratedBy ECO_0000203 NP176021.RAhkert6pGa0o1V05_lAm9BzqVLvKZVP-z6Oi3vq28J-Q130_provenance.